Your Location:
Home >
Browse articles >
Exploring Mechanism of Anti-atherosclerosis Effect of Huangqi Chifengtang Based on AMPK/PPARα Signaling Pathway and NLRP3 Inflammasome
Exploring Mechanism of Anti-atherosclerosis Effect of Huangqi Chifengtang Based on AMPK/PPAR
α Signaling Pathway and NLRP3 Inflammasome- Chinese Journal of Experimental Traditional Medical Formulae Vol. 32, Issue 1, Pages: 131-139(2026)
DOI: 10.13422/j.cnki.syfjx.20251863
Revised:2025-07-13 ,
Accepted:04 August 2025
Scan QR Code
AI Introduction
Full Text(HTML)
Figs( 4 ) Tabs( 9 )
References
Publication Info
Metrics
390
Views
278
Downloads
1
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Exploration of Zhuyuwan in Treatment of Atherosclerosis from Perspective of Lipid Transport Disorder
Isoflavones from Sojae Semen Praeparatum Regulate Lipid Metabolism in Atherosclerotic Mice Through PPARγ/LXRα/ABCA1 Signaling Pathway
Regulatory Effect and Mechanisms of Liuhuang Zhike Prescription on Glycemic Control in db/db Mice via AMPK/Akt/GSK-3β Signaling Pathway
Expert Consensus on Clinical Application of SkinPro Ointment
Differential Analysis of Clinical Features and Outcomes Between Syndrome of Combined Phlegm and Stasis and Syndrome of Dampness-heat Internal Accumulation in Hepatic Wilson's Disease
Related Author
SONG Wei
ZHANG Zhongyi
QIU Hairong
ZHAO Mei
ZHOU Zubing
SHEN Tao
ZHANG Yong
Jing-xin MA
Related Institution
Chengdu University of Traditional Chinese Medicine (TCM)
Hospital of Chengdu University of TCM
Hubei Minzu University
Institute of TCM, Sichuan Academy of Chinese Medicine Sciences
Guizhou University of Traditional Chinese Medicine


